HCW Biologics Inc. - Common Stock (HCWB)
5.5900
+2.2700 (68.37%)
NASDAQ · Last Trade: Sep 14th, 3:49 AM EDT
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · September 12, 2025
Via Benzinga · September 12, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · September 12, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · September 12, 2025
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · September 12, 2025
Via Benzinga · September 12, 2025
Via Benzinga · September 12, 2025
HCW Biologics' stock jumped 102.72% to $6.73 after the company revealed the successful development of second-generation T-cell engagers for solid tumors.
Via Benzinga · September 12, 2025
Via Benzinga · August 26, 2025
HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.
Via Benzinga · August 25, 2025
Via Benzinga · August 25, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · August 25, 2025
Via Benzinga · August 25, 2025
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · August 25, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · August 25, 2025
HCW Biologics shares jump after unveiling TRBC-based fusion therapy that enhances immune response and shows strong preclinical results in solid tumors.
Via Benzinga · August 25, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · August 25, 2025
Via Benzinga · August 25, 2025
Via Benzinga · July 25, 2025
Via Benzinga · July 18, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 18, 2025
Via Benzinga · July 16, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · May 13, 2025